FSNUY

14.0201.82%
MM

Marc-Alexander Mahl

Member of Management Board

Dr. Marc-Alexander Mahl is Member of Management Board of Fresenius SE & Co. KGaA from November 1, 2026. Dr. Mahl is Member of Management Board & President Pharma, Medical Nutrition and Sustainability of Fresenius Kabi Aktiengesellschaft. Dr. Mahl has headed Fresenius' Pharma and Nutrition businesses since May 2023. In addition, he oversees sustainability activities in these businesses. Mahl has been with Fresenius since July 2001, with a brief interruption and has since held various management positions with regional and global responsibilities. Since 2011, he has been responsible for the global Pharma business. In parallel, Mahl served as President of Medicines for Europe and as a member of the Executive Committee of the German industry association for specialized nutrition. Mahl studied medicine, is a specialist in transfusion medicine and holds an MBA from INSEAD.

Positions